Autopsy report · NCT03671304
Mobile Intervention - Physical Activity in Cancer Treatment
Cause of deathFunding or business
“The study was prematurely discontinued, the application utilized with the fitbit is no longer being supported.”
Life of this trial
- Registered 2 years 2 months before it started.
- Ran for about 1 year 1 month before it stopped.
- 8 participants enrolled.
- Results were posted on the registry 1 year 1 month after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Na
- Sponsor
- University of Texas Southwestern Medical Center
- Sponsor type
- University, hospital or other
- Conditions
- Carcinoma, Renal Cell
- Interventions
- Fitbit Versa
- Participants
- 8
- Sites
- 1
- Countries
- United States
Trials that died the same way
- Effect of Fish Oil (Omega-3 Fatty Acids) on Arteries
“The study was discontinued early due to lack of funding and slow enrollment” - Prospective Comparison of Revolve™ and AuraGen 123 With AuraClens™ in Autologous Fat Grafting to the Breast
“Study discontinued due to lack of subject follow-up.” - Real-Life Use of Transabdominal Restorelle® Meshes in Apical Prolapse Repair
“From June 08, 2024, the study device was no longer marketed in France. Therefore, the sponsor decided to terminate the study prematurely.” - Use Muscadine Wine Nutraceuticals to Improve Brain Health, Cognition, and Mental Health
“Funding for this study was discontinued by the sponsor after the first year.” - KYSA-1: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Refractory Lupus Nephritis
“Study discontinued due to sponsor decision.”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.